University of Illinois President Tim Killeen on Monday honored 28 key leaders of the system’s COVID-19 response with the Presidential Medallion, including 10 from the IGB. The medallion is the highest honor that the system president can bestow.
A new resource is available to help guide teachers and school administrators as they reopen schools amid the ongoing COVID-19 pandemic, assembled by researchers and experts at the University of Illinois Urbana-Champaign.
As vaccines for the virus that causes COVID-19 become more accessible, more communities and schools are reopening. However, no vaccines have been approved for children under 16 to date, leaving school districts with many questions to navigate as they reopen and plan for the 2021-22 school year.
Antifungal drug improves key cystic fibrosis biomarkers in clinical study
BY
December 19, 2020
Share
A drug widely used to treat fungal infections improved key biomarkers in lung tissue cultures as well as in the noses of patients with cystic fibrosis, a clinical study by researchers at the University of Illinois Urbana-Champaign and the University of Iowa found.
Cystic fibrosis is caused by a missing or defective ion channel in the lining of the lungs, called CFTR. This leaves patients vulnerable to lung infections. Treatments called modulators can help some but not all patients, based on which type of genetic mutation causes the symptoms.
It sometimes seems a million doesn’t command quite the same attention that it used to. It isn’t mathematically special. And in today’s society, it isn’t even unusually large. We now live in a world where the population is measured in billions, economies are scaled in trillions and computer calculations are counted by the quadrillion.
But it takes on a very special significance when you’re talking about looking after the well-being of your community in the middle of a globally devastating pandemic.
A collaborative effort at the University of Illinois to support COVID-19 testing is winding down, but not before it produced enough materials to support some 200,000 coronavirus tests across the state.
An approved drug normally used to treat fungal infections could also do the job of a protein channel that is missing or defective in the lungs of people with cystic fibrosis, operating as a prosthesis on the molecular scale, says new research from the University of Illinois and the University of Iowa.
